Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.

Slides:

Advertisements

Similar presentations

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

Advertisements

The Epidemiology of Hemoglobin Levels in Patients With Type 2 Diabetes

Renal Function Testing

Independent and Joint Associations of Nutritional Status Indicators With Mortality Risk Among Chronic Hemodialysis Patients in the Dialysis Outcomes and.

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A

Peritoneal dialysis American Journal of Kidney Diseases

Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and.

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Care of the Undocumented Immigrant in the United States With ESRD

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

A Decade After the KDOQI CKD Guidelines

The US Renal Data System “Pie Chart of Death”

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Recognition for Conservative Care in Kidney Failure

Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): Nutrition guidelines, indicators, and.

Hai-yan Wang, MD, American Journal of Kidney Diseases

Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care Douglas S.

Meeting the challenges of the new K/DOQI guidelines

Wayne Trebbin, MD, Peter Monteleone, MD

The DOPPS Practice Monitor for US Dialysis Care: Update on Trends in Anemia Management 2 Years Into the Bundle Douglas S. Fuller, MS, Ronald L. Pisoni,

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

A Decade After the KDOQI CKD Guidelines: A Historical Perspective

Iain C. Macdougall, MD American Journal of Kidney Diseases

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States Mae Thamer, PhD, Yi Zhang, DDS, MS,

Quiz Page July 2012 American Journal of Kidney Diseases

Donna L. Mapes, DNSc, Jennifer L

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Rajiv Saran, MD, MS, Bernard J. Canaud, MD, Thomas A

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.

Risks and Outcomes of Acute Kidney Injury Requiring Dialysis After Cardiac Transplantation Janet M. Boyle, MD, Soundous Moualla, MD, Susana Arrigain,

The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral and Bone Disorder.

Prevalence and Severity of Renal Disease in Familial Dysautonomia

American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD

Drug Dose Adjustments in Patients With Renal Impairment

Erratum American Journal of Kidney Diseases

Volume 70, Issue 10, Pages (November 2006)

Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target American.

Risk for Incident Renal Dialysis in a Managed Care Population

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

David A. Goodkin, MD, Eric W

Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD

Removal of Dabigatran by Hemodialysis

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Differences in Blood Transfusion Trends Between US and UK Centers

Why measure serum albumin levels?

Anemia After Renal Transplantation

Erratum American Journal of Kidney Diseases

Ronald L. Pisoni, PhD, MS, Brenda W. Gillespie, PhD, David M

The Use of Vaccines in Adult Patients With Renal Disease

August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD

In the Literature: Cognitive Impairment in Hemodialysis Patients

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

Anil K. Saxena, MD, B.R. Panhotra, MD, PhD, MNAMS

Supportive care for patients with renal disease: Time for action

Dialysis Research and N-of-1 Trials: Made for Each Other?

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

Maristela Böhlke, PhD American Journal of Kidney Diseases

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Presentation transcript:

Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings Francesco Locatelli, MD, Ronald L. Pisoni, PhD, MS, Tadao Akizawa, MD, PhD, José M. Cruz, MD, Peter B. DeOreo, MD, Norbert H. Lameire, MD, Philip J. Held, PhD American Journal of Kidney Diseases Volume 44, Pages 27-33 (November 2004) DOI: 10.1053/j.ajkd.2004.08.008 Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 Mean hemoglobin concentrations among prevalent hemodialysis patients (on dialysis >180 days) and incident dialysis patients (within 7 days of first hemodialytic treatment) in DOPPS II. To convert hemoglobin in g/dL to g/L, multiply by 10. (Data from Pisoni et al.20) American Journal of Kidney Diseases 2004 44, 27-33DOI: (10.1053/j.ajkd.2004.08.008) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 2 Percentage of patients with hemoglobin <11 g/dL (<110 g/L) among prevalent hemodialysis patients (on dialysis >180 days) and incident dialysis patients (within 7 days of first hemodialytic treatment) in DOPPS II. (Data from Pisoni et al.20) American Journal of Kidney Diseases 2004 44, 27-33DOI: (10.1053/j.ajkd.2004.08.008) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 3 Time trend in rHuEpo use and mean hemoglobin concentration by time since starting hemodialysis. To convert hemoglobin in g/dL to g/L, multiply by 10. Reprinted from Locatelli et al,19 with the permission of the Oxford University Press, © 2003 European Renal Association—European Dialysis and Transplant Association. American Journal of Kidney Diseases 2004 44, 27-33DOI: (10.1053/j.ajkd.2004.08.008) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 4 Relationship between patient hemoglobin concentration and adjusted relative risks of death and hospitalization in DOPPS I. To convert hemoglobin in g/dL to g/L, multiply by 10. Reprinted from Pisoni et al,20 © 2004, with permission from the National Kidney Foundation. American Journal of Kidney Diseases 2004 44, 27-33DOI: (10.1053/j.ajkd.2004.08.008) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions